Abstract
We examined half time (Pt 1/2) and distribution volume (Vd) of V in 22 (16 preterm and 6 term) critically ill neonates. V was dosed: 20 mg/kg/d OD (<800g), 30 mg/kg/d OD (800-1200g), 40 mg/kg/d TID (> 1200g), as 60 min infusion. Target concentrations were 20-40 mcg/ml (pk) and <10 mcg/ml (tr). 88 drug levels were drawn: peak (pk) level 60 min after end of infusion, trough (tr) level prior to the next dose. V concentrations were measured by fluorescence polarisation immunoassay (TDX Abbott). Data are m ± sD:
Results: Pt 1/2 is decreasing with PCA, but Vd is not related to PCA in our population. 36% (16/44) of pk levels were not within the therapeutic range: 2 below, 14 above the range. 30% (13/44) of tr levels were above the therapeutic range. In 64% (28/44) the dosing schedule was changed according to pharmacokinetic data: increased dose (7), decreased dose (15), lengthened interval (12), shortened interval (3). The adjusted average dosage in our population was: for PCA < 30 wks: 17 mg/kg every 25 h; PCA 30-37 wks: 17 mg/kg every 20 h; PCA > 37 wks: 18 mg/kg every 19 h.
Conclusion: Therapeutic drug monitoring of V is essential because of high interpatient variability, to avoid toxicity and to ensure therapeutic blood levels. We suggest a revision of current dosing recommendations in preterm neonates.
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pecar, A., Lindner, W., Mönch, V. et al. PHARMACOKINETICS OF VANCOMYCIN (V) IN TERM AND PRETERM NEONATES. Pediatr Res 32, 624 (1992). https://doi.org/10.1203/00006450-199211000-00116
Issue Date:
DOI: https://doi.org/10.1203/00006450-199211000-00116